JP2023540599A5 - - Google Patents
Info
- Publication number
- JP2023540599A5 JP2023540599A5 JP2023515394A JP2023515394A JP2023540599A5 JP 2023540599 A5 JP2023540599 A5 JP 2023540599A5 JP 2023515394 A JP2023515394 A JP 2023515394A JP 2023515394 A JP2023515394 A JP 2023515394A JP 2023540599 A5 JP2023540599 A5 JP 2023540599A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- expression cassette
- gene delivery
- sequence encoding
- cassette according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382792.8 | 2020-09-07 | ||
| EP20382792.8A EP3964265A1 (en) | 2020-09-07 | 2020-09-07 | Mesenchymal stem cells co-expressing cxcr4 and il-10 and uses thereof |
| PCT/EP2021/074612 WO2022049306A1 (en) | 2020-09-07 | 2021-09-07 | Mesenchymal stem cells co-expressing cxcr4 and il-10 and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540599A JP2023540599A (ja) | 2023-09-25 |
| JP2023540599A5 true JP2023540599A5 (https=) | 2024-08-02 |
Family
ID=72473480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515394A Pending JP2023540599A (ja) | 2020-09-07 | 2021-09-07 | Ｃｘｃｒ４及びｉｌ－１０を共発現する間葉系幹細胞並びにその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230398152A1 (https=) |
| EP (2) | EP3964265A1 (https=) |
| JP (1) | JP2023540599A (https=) |
| KR (1) | KR20230082622A (https=) |
| CN (1) | CN116507733A (https=) |
| AU (1) | AU2021337798A1 (https=) |
| BR (1) | BR112023004167A2 (https=) |
| CA (1) | CA3194344A1 (https=) |
| MX (1) | MX2023002741A (https=) |
| SA (1) | SA523442866B1 (https=) |
| WO (1) | WO2022049306A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020092839A1 (en) | 2018-10-31 | 2020-05-07 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| EP3873540A4 (en) | 2018-10-31 | 2022-07-27 | Mayo Foundation for Medical Education and Research | METHODS AND MATERIALS FOR THE TREATMENT OF CANCER |
| CN115927178A (zh) * | 2022-11-17 | 2023-04-07 | 华夏源(上海)生物科技有限公司 | 一种检测间充质干细胞抑制b细胞分化为浆细胞的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2065396A1 (en) * | 1996-08-30 | 2009-06-03 | Human Genome Sciences, Inc. | Interleukin-19 |
| US20090074733A1 (en) * | 2005-12-09 | 2009-03-19 | Medin Jeffrey A | Thymidylate kinase mutants and uses thereof |
| CA2784861A1 (en) * | 2009-12-21 | 2011-07-14 | Pharmathene, Inc. | Recombinant butyrylcholinesterases and truncates thereof |
| PL3242933T3 (pl) * | 2015-01-08 | 2019-08-30 | Apceth Gmbh & Co. Kg | Zmodyfikowane genetycznie mezenchymalne komórki macierzyste wykazujące ekspresję alfa-1 antytrypsyny (aat) |
| JP7086928B2 (ja) * | 2016-07-25 | 2022-06-20 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 改変されたナチュラルキラー細胞を生成する方法および使用方法 |
| AU2019291069B2 (en) * | 2018-06-19 | 2026-02-19 | Fondazione Centro San Raffaele | Production of engineered dendritic cells and uses thereof |
-
2020
- 2020-09-07 EP EP20382792.8A patent/EP3964265A1/en not_active Withdrawn
-
2021
- 2021-09-07 EP EP21766690.8A patent/EP4210834A1/en active Pending
- 2021-09-07 CA CA3194344A patent/CA3194344A1/en active Pending
- 2021-09-07 JP JP2023515394A patent/JP2023540599A/ja active Pending
- 2021-09-07 MX MX2023002741A patent/MX2023002741A/es unknown
- 2021-09-07 WO PCT/EP2021/074612 patent/WO2022049306A1/en not_active Ceased
- 2021-09-07 KR KR1020237011997A patent/KR20230082622A/ko active Pending
- 2021-09-07 AU AU2021337798A patent/AU2021337798A1/en active Pending
- 2021-09-07 CN CN202180075229.XA patent/CN116507733A/zh active Pending
- 2021-09-07 BR BR112023004167A patent/BR112023004167A2/pt unknown
- 2021-09-07 US US18/025,074 patent/US20230398152A1/en active Pending
-
2023
- 2023-03-07 SA SA523442866A patent/SA523442866B1/ar unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540599A5 (https=) | ||
| JP6976244B2 (ja) | 心臓状態および他の病態の処置のための複数の生物学的に活性なポリペプチドを単一のベクターから発現させるための組成物および方法 | |
| JP2024178382A5 (https=) | ||
| JP2025184979A5 (https=) | ||
| Mastellos et al. | Complement: structure, functions, evolution, and viral molecular mimicry | |
| CA2529179A1 (en) | Recombinant adeno-associated virus vector for treatment of alzheimer disease | |
| JP2011525363A5 (https=) | ||
| RU2012105281A (ru) | Двойной вектор для подавления вируса иммунодефицита человека | |
| EA026926B1 (ru) | Композиции, содержащие улучшенные генетические конструкции il-12, вакцины, иммунотерапевтические составы и способы их применения | |
| JP2021532776A5 (https=) | ||
| WO2003088899A3 (en) | Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof | |
| JP2021530971A5 (https=) | ||
| JP2024533316A5 (https=) | ||
| JP2018537089A5 (https=) | ||
| RU2005113692A (ru) | Вакцина против hcv | |
| KR20230018378A (ko) | 골수 세포 및 미세아교세포에서 치료 단백질을 특이적으로 발현하는 바이러스 벡터 | |
| JP2024546641A5 (https=) | ||
| JP2024503091A5 (https=) | ||
| CA2933620A1 (en) | Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1 | |
| EA011037B1 (ru) | Олигомерные пептиды и их применение для лечения вич инфекций | |
| CN104292337A (zh) | 猪融合干扰素 | |
| JP2007536891A5 (https=) | ||
| RU2017104284A (ru) | Выделенные полипептиды cd44 и их применение | |
| WO2024261330A1 (en) | Brick1 for use in treating myocardial diseases | |
| JP2012501351A5 (https=) |